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Characterization of cutaneous and
articular sensory neurons
Ines da Silva Serra, MPharm1,2,*, Zoe´ Husson, MSc, PhD1,*,
Jonathan D. Bartlett1 and Ewan St. John Smith, MPharmacol, PhD1
Abstract
Background: A wide range of stimuli can activate sensory neurons and neurons innervating specific tissues often have
distinct properties. Here, we used retrograde tracing to identify sensory neurons innervating the hind paw skin (cutaneous)
and ankle/knee joints (articular), and combined immunohistochemistry and electrophysiology analysis to determine the
neurochemical phenotype of cutaneous and articular neurons, as well as their electrical and chemical excitability.
Results: Immunohistochemistry analysis using RetroBeads as a retrograde tracer confirmed previous data that cutaneous
and articular neurons are a mixture of myelinated and unmyelinated neurons, and the majority of both populations are
peptidergic. In whole-cell patch-clamp recordings from cultured dorsal root ganglion neurons, voltage-gated inward currents
and action potential parameters were largely similar between articular and cutaneous neurons, although cutaneous neuron
action potentials had a longer half-peak duration (HPD). An assessment of chemical sensitivity showed that all neurons
responded to a pH 5.0 solution, but that acid-sensing ion channel (ASIC) currents, determined by inhibition with the
nonselective acid-sensing ion channel antagonist benzamil, were of a greater magnitude in cutaneous compared to articular
neurons. Forty to fifty percent of cutaneous and articular neurons responded to capsaicin, cinnamaldehyde, and menthol,
indicating similar expression levels of transient receptor potential vanilloid 1 (TRPV1), transient receptor potential ankyrin 1
(TRPA1), and transient receptor potential melastatin 8 (TRPM8), respectively. By contrast, significantly more articular
neurons responded to ATP than cutaneous neurons.
Conclusion: This work makes a detailed characterization of cutaneous and articular sensory neurons and highlights the
importance of making recordings from identified neuronal populations: sensory neurons innervating different tissues have
subtly different properties, possibly reflecting different functions.
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Background
Throughout the animalia kingdom, organisms possess
sensory neurons that enable them to detect their external
and internal environments, some of which are dedicated
to the transduction of solely noxious stimuli, so-called
nociceptors.1–5 The majority of cell bodies of sensory
neurons are located in the dorsal root ganglia (DRG,
which innervate the body) and trigeminal ganglia
(which innervate the head), and neuronal culture of
these ganglia is a widely used technique to investigate
sensory neuron function.6
The DRG are often taken either from the entire
animal or from a relevant anatomical location, for exam-
ple, in studies where the sciatic nerve has been injured,
lumbar DRG are often used. However, DRG neurons
are not a uniform population and diﬀerent subtypes have
been described based on their electrophysiological prop-
erties and immunochemical proﬁles. Single-cell RNA
sequencing analysis of mouse lumbar DRG neurons
has recently demonstrated that these neurons can be
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split into 11 diﬀerent populations based upon RNA
expression,7 and functional analysis conducted by a variety
of research groups has also demonstrated that isolated
mouse and rat DRG neurons can be split into diﬀerent
groups depending upon their electrical, thermal, and chem-
ical sensitivity.8–12 In vitro diﬀerences are observed
between peptidergic and nonpeptidergic neurons, distin-
guished by their isolectin B4 (IB4) binding, an in vitro
marker of nonpeptidergic neurons.13 For example, acid
evokes transient, rapidly inactivating inward currents
that are mediated by acid-sensing ion channels (ASICs)
more frequently in IB4-negative neurons than in IB4-posi-
tive neurons,8–10,14 and IB4-positive neurons have longer
action potential durations than IB4-negative neurons.11,12
To identify the nature and characterize the properties
of neurons innervating speciﬁc sites, it is necessary to
speciﬁcally label the diﬀerent neuronal populations
within the DRG. Retrograde tracing involves injecting
a small volume of ﬂuorescent tracer at the site of interest
(e.g. skin/joints), allowing, after a few days, DRG to be
cultured and imaging methods used to identify labeled
neurons. Using this technique, we have previously iden-
tiﬁed that transient receptor potential vanilloid 4
(TRPV4) makes a signiﬁcant contribution to the osmo-
sensitivity of mouse hepatic aﬀerent neurons,15 others
have demonstrated that ASIC3 produces acid sensitivity
in rat cardiac aﬀerents16 and is the major contributor to
the acid sensitivity of rat dorsal paw skin aﬀerents,17 and
other research groups have determined the properties of
sensory neurons innervating a wide range of tissues.18–22
Previous studies using retrograde tracing in mice and
rats showed that neurons innervating joints and skin
have diﬀerent neurochemical proﬁles. Approximately,
50% of ankle/knee joint aﬀerents are positive for calci-
tonin gene-related peptide (CGRP, a marker of peptider-
gic neurons, expressed by both myelinated and
unmyelinated neurons) while knee aﬀerent neurons
have either been found to be IB4-negative23–25 or to dis-
play very low (1.5%) levels of IB4 binding.26 In contrast,
neurons innervating the skin in various sites of the body
are more frequently IB4-positive, although to varying
degrees,27–29 and one study found that approximately
20% of plantar skin aﬀerents are IB4-positive.30
Additionally, the receptor for nerve growth factor,
TrkA, which is expressed by peptidergic neurons, is
expressed by approximately 40% of rat neurons inner-
vating the footpad.31 However, in none of these studies
was electrophysiology conducted to further characterize
functional properties of identiﬁed neurons. For example,
electrophysiological analysis of action potential wave-
form can be used to determine the likelihood that a
neuron is a nociceptor or a mechanoreceptor: nocicep-
tors have longer action potential durations, often char-
acterized by an inﬂection, or hump, on their falling
phase,32 even in an isolated preparation.
In this study, we retrogradely labeled cutaneous (hind
paw plantar skin) and articular (ankle and knee joints)
sensory neurons and combined immunohistochemistry
and whole-cell patch clamp recordings to characterize
their comparative neurochemical phenotypes and their
relative electrical and chemical excitabilities. We found
that both cutaneous and articular neurons are mostly
peptidergic and that cutaneous neurons have larger
ASIC-mediated currents, whereas articular neurons are
more likely to respond to ATP.
Methods
Animals
All experiments were conducted in accordance with the
United Kingdom Animal (Scientiﬁc Procedures)
Act 1986 under a Project License (70/7705) granted to
E. St. J. S. by the Home Oﬃce; the University of
Cambridge Animal Welfare Ethical Review Body also
approved procedures. Female C57/bl6 mice (four to six
weeks) were used in this study because rheumatoid arth-
ritis is more prevalent in females and thus they are our
focus and were bred in house. Mice were conventionally
housed in groups of up to ﬁve mice per cage with nesting
material and a red plastic shelter; the holding room was
temperature controlled (21C) and mice were on a
normal 12-h light/dark cycle with food and water avail-
able ad libitum. Technicians observed mice daily and a
study plan outlining the procedures, with a description of
possible adverse eﬀects, was kept in the room where mice
were housed.
Retrograde tracer injections
In a designated procedure room, animals were weighed
and anaesthetized using ketamine (100mg/kg) and xyla-
zine (10mg/kg); injectable anesthesia was used because it
allows subsequent manipulation of mice to enable
administration of retrograde tracer. Lumaﬂuor rhoda-
mine-labeled latex spheres (0.02–2 mm), RetroBeads,33
were diluted 1:2.5 in MilliQ water. Once no withdrawal
reﬂexes were observed, mice received retrograde tracer
subcutaneous injections to the lateral (1 ml), central
(1 ml), and medial (1 ml) plantar aspects of both hind
paws to label cutaneous aﬀerents across the plantar sur-
face of the hind paws. Alternatively, to label articular
aﬀerent neurons, retrograde tracer injections were
administered to both hind limb knees (1.5 ml) and
ankles (2.5 ml). Injections were performed using a
10 ml Hamilton syringe and a 30 G needle. Mice were
housed in a recovery chamber (30C) and observed by
a theatre technician until fully alert, at which point they
were returned to the holding room. For immunohisto-
chemistry experiments, four mice were used for the
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cutaneous group and four mice for the articular group.
For electrophysiology experiments, 5 mice were used for
the cutaneous group and 10 mice for the articular group;
more mice were needed for the articular group because of
the relative paucity of labeled neurons observed in cul-
ture. In accordance with the 3Rs, brains were removed
from mice for use in other experiments to reduce the
total number of animals used.
DRG dissection and culture
Mice were killed four to six days after retrograde tracer
injection by cervical dislocation and lumbar (L2–L5)
DRG were removed and collected in Ca2þ-/Mg2þ-free
phosphate-buﬀered saline (PBS); skin, or knees and
ankles were always dissected to ensure that appropriate
administration of retrograde tracer had been performed.
DRG were subsequently incubated in collagenase IV
(500 mg/ml, 30min, 37C, Sigma-Aldrich, C5138, St.
Louis, MO) in DRG culture medium (Dulbecco’s
Modiﬁed Eagle Medium; Life Technologies, 21331-020,
Carlsbad, CA) containing 10% heat-inactivated horse
serum (Life Technologies, 26050-088), 2mM glutamine,
0.4% glucose, 100U penicillin, and 100mg/ml strepto-
mycin (Life Technologies), followed by incubation in
trypsin (0.0125%, 25min, 37C, Sigma T4174). DRGs
were washed twice with DRG culture medium and then
triturated using 20G (5) and 23G (2–3) needles.
Dissociated neurons were plated on to poly-D-lysine-
coated MatTeK glass bottom dishes (P35GC-1.5-14-C),
which had been coated with laminin (20 mg/ml, 2 hr at
37C before washing twice with water, Life
Technologies 23017015). Neurons were kept at 37C in
5% CO2.
Immunohistochemistry
Mice were killed four days following retrograde tracer
injection by cervical dislocation and lumbar (L2–L5)
DRG were removed and collected in 4% paraformalde-
hyde (PFA) on ice. After 30-min incubation, DRG were
placed in 30% sucrose overnight at 4C for cryoprotec-
tion. DRG were subsequently embedded in optimum
cutting temperature (OCT) compound and stored at
20C. DRG sections (12 mm) were cut using a Leica
Cryostat CM3000, mounted on to Superfrost Plus micro-
scope slides (Thermo Scientiﬁc), and stored at 20C
until processed.
Sections were blocked with a pre-incubation buﬀer of
1% bovine serum albumin (BSA; Sigma, A7906) for 2 h
at room temperature, except for the slides for use with
anti-peripherin antibody, which were blocked with a 2%
BSA and 10% goat serum (Life Technologies, 10658654)
buﬀer and the ones for use with the anti-CGRP antibody
which were blocked with a 2% BSA and 4% donkey
serum (Sigma, D9663) buﬀer. Sections were subse-
quently incubated overnight, with primary antibodies
at 4C: goat anti-transient receptor potential vanilloid
1 (TRPV1; Santa Cruz Biotechnology sc-12498, 1:1000)
in a 1% BSA and 0.1% ﬁsh gelatin (Sigma, G7041)
buﬀer; rabbit anti-NF-200 (Sigma N4142, 1:1000) in a
5% goat serum buﬀer; chicken anti-peripherin (Abcam
ab39374, 1:500) in a 2% BSA and 4% goat serum buﬀer;
rabbit anti-CGRP (Sigma C8198, 1:10.000) in a 2% BSA
and 4% donkey serum buﬀer. After three rinses of the
antibody slides in tris-buﬀered saline (TBS), sections
were incubated with appropriate Alexa 488-conjugated
secondary antibodies (goat anti-chicken, Abcam
ab150169; donkey anti-goat, Life Technologies A11055;
and goat anti-rabbit, Life Technologies A11008; all used
at 1:1000) for 2 hrs at room temperature and ﬁnally
rinsed three times in TBS, once with MilliQ water, and
mounted using FluorSave (Merck). For IB4-Alexa-488
(IB4, Life Technologies, 4 mg/ml) staining, slides were
incubated in the electrophysiology extracellular solution
(see below) for 20min at room temperature, rinsed three
times with TBS, once with MilliQ water, and then
mounted using FluorSave.
Sections were analyzed using a Zeiss Aksioskop
microscope; nonconsecutive sections were analyzed to
prevent counting the same cell twice, and the same
number of sections was counted from each animal.
Pictures were taken for each section both for the bright
ﬁeld and ﬂuorescent channels as appropriate for the anti-
body and Lumaﬂuor beads, using a 40 objective. The
exposure time used for each particular antibody was the
same for each section so that the quality of staining was
comparable between sections.
Sections were analyzed using ImageJ software. Each
neuron was detected on the bright ﬁeld image and
deﬁned as a region of interest (ROI) by manual drawing
of its perimeter. ROI statistics (notably the mean inten-
sity) were then retrieved for each ROI on individual
ﬂuorescent channel pictures (for RetroBeads and
antibodies). For determination of the CGRP, peripherin,
NF-200, and TRPV1 immunoreactivity, a custom rou-
tine using GNU R was used. For each section, the mean
intensity distribution was plotted revealing a bimodal
distribution. The peak at low intensities values repre-
sented the population of negative cells and could be
approximated by a Gaussian function. A long tail at
higher intensity values represented the strongly labeled
cells, which were considered positive when their mean
intensity value was above a cut-oﬀ value deﬁned as two
times the standard deviation above the mean intensity
value of the population of negative cells. Due to the
membrane labeling of cells by IB4, it was not possible
to use the cell intensity method described earlier; instead,
labeling was determined manually by two independent
experimenters. For all markers, a cell was considered
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as labeled by Lumaﬂuor RetroBeads if ﬁve or more
beads were present within its cell body.
Data were analyzed and plotted using Excel
(Microsoft) and Prism (GraphPad). A one-way analysis
of variance (ANOVA) and Tukey’s post hoc test were
used to analyze diﬀerences in the percentage of
RetroBeads in diﬀerent lumbar DRG following cutane-
ous or articular injection; the unit of analysis was the
number of images analyzed for each ganglia and two
to ﬁve images were analyzed per lumbar level per
mouse. A one-way ANOVA and Tukey’s post hoc
test were used to analyze diﬀerences in the frequency of
colocalization of RetroBeads with each marker used fol-
lowing cutaneous or articular injection; the unit of ana-
lysis was the number of mice per condition (n¼ 4 per
condition).
Electrophysiology
DRG neuron recordings were made on the day after dis-
section (24–32 h post-dissection), using the following
solutions: extracellular (in mM)—NaCl (140), KCl (4),
CaCl2 (2), MgCl2 (1), glucose (4), HEPES (10), adjusted
to pH 7.4 with NaOH; intracellular (in mM)—KCl (110),
NaCl (10), MgCl2 (1), EGTA (1), and HEPES (10),
adjusted to pH 7.3 with KOH. Acidic extracellular
solutions were made using MES (pH 5.0). Prior to begin-
ning recordings, neurons were incubated in IB4-Alexa-
488 (2 mg/ml) for 15min; cells were then washed with
extracellular solution for 10min. We only made record-
ings from neurons in which 5þ RetroBeads could be
observed and only neurons in which an action potential
could be generated and that had a resting membrane
potential of 40mV or more negative were used for
experiments. Patch pipettes were pulled (P-97, Sutter
Instruments) from borosilicate glass capillaries
(Hilgenberg) and had a resistance of 3–6M.
Recordings were made using an EPC-10 ampliﬁer
(HEKA) and Patchmaster software (HEKA). Whole-
cell currents were recorded at 20 kHz, pipette and mem-
brane capacitance was compensated using Patchmaster
macros, and series resistance was compensated by
>60%. In DRG neurons, a standard voltage-step proto-
col was used, whereby cells were held at 120mV for
240ms before stepping to the test potential (50mV to
þ50mV in 5mV increments) for 40ms, returning to the
holding potential (60mV) for 200ms between sweeps;
leak subtraction was used to minimize capacitive cur-
rents. To generate action potentials, we used repetitive
80ms current injections from 10 pA to 150 pA in 10 pA
steps (100–1000 pA in 50 pA steps for larger cells) and the
ﬁrst action potential evoked was analyzed; a hump on the
repolarization phase, determined by plotting dV/dt, was
used to classify a cell as a nociceptor. Subsequently, cells
were exposed to a 5-s pulse of pH 5.0, 50 mMATP (Sigma
A26209), 1 mM capsaicin (Sigma, 21750), 100 mM cinna-
maldehyde (Merck, 802505), 100 mM menthol (Alfa
Aesar A1047418), applied in a random order with a 30-
s wash time in between diﬀerent stimuli; random order of
stimulation was conducted to preclude any potential sti-
mulus-mediated sensitization biasing results. Responses
to acidic solutions were classiﬁed as transient or sustained
based upon the initial response, e.g. a rapidly inactivating
transient current, followed by a sustained current during
the acid application, was classiﬁed as a transient
response. To determine the contribution of ASICs to
transient acid-mediated responses, the nonselective
ASIC antagonist benzamil (250mM, Santa Cruz sc-
201070) was applied for 60 s before measuring the response
to the pH 5.0 solution again; a 60-s wash period then took
place, followed by a ﬁnal 5-s pH 5.0 stimulation. Images of
neurons using a 40 objective were captured using a Zyla
5.5 sCMOS camera (Andor), followed by subsequent ana-
lysis in ImageJ, having used a stage micrometer to convert
pixel values into mm.
Current amplitude was measured in Fitmaster
(HEKA) by taking the maximum peak response and sub-
tracting the mean baseline amplitude in the preceding
10ms (voltage-gated currents) or 2.5 s (chemosensitive
currents); current amplitude was normalized for cell size
by dividing by cell capacitance. Action potential param-
eters (amplitude, half-peak duration [HPD], and after-
hyperpolarization duration [AHP]) were measured in
Igor Pro using in house macros. Data are expressed as
mean standard error of the mean (SEM). Paired t tests
were used to compare the eﬀects of antagonists on
proton-gated currents within both cutaneous and articu-
lar neuron data sets; unpaired t tests were used to com-
pare parameters, such as resting membrane potential and
transient acid-gated current amplitude, between cutane-
ous and articular neuron data sets. Fisher’s exact test
was used to compare the frequency of response to diﬀer-
ent agonists between cutaneous and articular neurons.
Results
Retrograde tracing of articular and
cutaneous afferents
Initial control experiments demonstrated that following
injection of RetroBeads to either cutaneous or articular
regions, no RetroBeads were observed in thoracic ganglia
(data not shown), i.e. as others have found,33 RetroBeads
do not diﬀuse far from the injection site. Similarly, when
only the left or right hind limb was used for injection, no
RetroBeads were found in lumbar DRG from the contra-
lateral side (data not shown).
Following articular RetroBead injection, the L2 and
L5 DRG had the smallest number of labeled
neurons (0.58 0.26%, and 0.58 0.18%, respectively,
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Figure 1(a) and (b)) and the L4 DRG contained the
highest percentage (1.78 0.35%, Figure 1(b)), a ﬁnding
which replicates that of others.24 Following cutaneous
RetroBead injection, the L3 and L4 DRG were again
found to contain the highest percentage of labeled neu-
rons with the L4 DRG containing the highest percentage
(6.66 0.62%, Figure 1(c)), an observation similar to
what others have found.34 In general, more DRG
neurons were labeled following cutaneous injection
than following articular injection and when comparing
the L3 and L4 DRG, the increase was signiﬁcant
(p< 0.0001, Figure 1(b)).
Neurochemical phenotype of articular and
cutaneous afferents
We next investigated whether primary aﬀerent neurons
that innervate the ankles and knees have a similar neuro-
chemical phenotype to cutaneous primary aﬀerent neu-
rons. To ensure that the mice used for articular analysis
were neurochemically similar to those used for cutaneous
analysis, we ﬁrst analyzed L2–L5 DRG neurons in the
two sets of mice to determine the total percentage of
myelinated (NF-200 positive), unmyelinated (peripherin
positive), nonpeptidergic (IB4-positive), peptidergic
(CGRP positive) and TRPV1-expressing (TRPV1-posi-
tive) neurons; it should, however, be noted that NF-200
staining can occur in unmyelinated neurons.35 As
expected, the percentage of neurons positive for each
of these markers was not signiﬁcantly diﬀerent between
the two groups (data not shown). We next determined
the neurochemical proﬁles of articular and cutaneous
neurons (example micrographs are shown in
Figure 2(a)–(d)) by assessing colocalization between
RetroBead-labeled neurons and diﬀerent markers. A sig-
niﬁcantly greater proportion of labeled articular neurons
were peptidergic (CGRP positive) compared to nonpep-
tidergic (IB4-positive; 79.38 10.63% and 5.00 5.00%,
respectively, p< 0.01, Figure 2(e)). Similarly, articular
neurons were predominantly myelinated (NF-200 posi-
tive, 86.67 8.16%) compared to nonpeptidergic (IB4-
positive) and TRPV1-positive neurons (20.83 10.49%,
p< 0.01, Figure 2(e)). However, there was no signiﬁcant
diﬀerence between the proportion of myelinated
(NF-200 positive) and unmyelinated (peripherin positive,
45.83 18.48%) articular neurons. A similar pattern was
observed for cutaneous neurons where signiﬁcantly more
labeled neurons were peptidergic (CGRP positive) than
nonpeptidergic (IB4-positive; 84.88 2.83% and
26.01 10.11%, respectively, p< 0.05, Figure 2(f)).
Like articular neurons, there was no signiﬁcant diﬀer-
ence between the myelinated and unmyelinated popula-
tions (NF-200 and peripherin positive, 58.33 10.41%
and 38.18 16.63%, respectively; Figure 2(f)). Overall,
no signiﬁcant diﬀerences in the neurochemical proﬁles of
articular and cutaneous neurons were found.
Electrical excitability of articular and
cutaneous afferents
Articular and cutaneous aﬀerents were identiﬁed in cul-
ture by the presence of RetroBeads in the cell cytoplasm
and were further classiﬁed as being IB4-positive or IB4-
negative (Figure 3(a)). Of identiﬁed articular and
cutaneous neurons, 2/16 and 4/20 were IB4-positive,
respectively; because of the small number of IB4-positive
Figure 1. Retrograde labeling of articular and cutaneous neurons. (a) DRG section, black arrow indicates neuron containing multiple
RetroBeads. Quantification of percentage of neurons containing RetroBeads in L2–L5 DRG following injection of retrograde tracer to
articular (b) or cutaneous (c) sites. Numbers in brackets refer to number of retrogradely labeled neurons counted per conditions.
*p< 0.05 and ****p< 0.0001 between DRG in one set of animals; yyyyp< 0.0001 between DRG of articular compared with cutaneous
animals (one-way ANOVA and Tukey’s post hoc test). DRG: dorsal root ganglia; ANOVA: analysis of variance.
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Figure 2. Neurochemical phenotype of lumbar DRG and characterization of articular and cutaneous neuron neurochemical composition.
(a–d), example micrographs showing a bright field image of a lumbar DRG section (a), white asterisk shows a neuron that is peptidergic
(CGRP positive) (b) and contains RetroBeads (c), black asterisks denotes neurons that are CGRP positive but do not contain RetroBeads,
and (d) shows the merged image. (e and f) Percentage of lumbar DRG neurons (combined analysis of L2–L5) that colocalize RetroBeads
with different neurochemical markers following injection of retrograde tracer to articular (e) or cutaneous (f) sites (n¼ 4 animals in each
condition). Numbers in brackets refer to the number of RetroBeads labeled neurons upon which this analysis is based. *p< 0.05,
**p< 0.01 (one-way ANOVA and Tukey’s post hoc test). DRG: dorsal root ganglia; CGRP: calcitonin gene-related peptide; ANOVA:
analysis of variance.
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Figure 3. Electrical excitability of articular and cutaneous neurons. (a) Images of an articular neuron containing RetroBeads that is IB4-
negative. (b) Lower panel, example trace of voltage-gated currents evoked by the voltage-step protocol in the upper panel (see
Electrophysiology Section for more details). (c and d) IV curves for voltage-gated inward currents recorded in articular (n¼ 14) and
cutaneous (n¼ 18) neurons, respectively. (e) Example action potential evoked by current injection of 350 pA in a cutaneous neuron, red
arrows indicate how measurements of amplitude, HPD, and AHP were made; the red trace below the action potential shows a plot of dV/
dT, the asterisk denoting the prominent hump during repolarization. (f–h) action potential parameters:
(f) action potential threshold; (g) action potential AHP and (h) action potential HPD recorded in articular (n¼ 14) and cutaneous (n¼ 18)
neurons. *p< 0.05. IB4: isolectin B4; AHP: afterhyperpolarization duration; IV: current voltage relationship; HPD: half peak duration.
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neurons, no further analysis was made of IB4-positive
versus IB4-negative neurons. Of the neurons recorded,
there was no signiﬁcant diﬀerence in average diameter or
resting membrane potentials between articular and cuta-
neous neurons (Table 1).
To investigate the contribution of voltage-gated Naþ
currents to macroscopic voltage-gated inward currents,
we used a voltage-step protocol previously established
for this purpose.36 We observed that peak voltage-gated
inward currents in cutaneous neurons were similar to
those in articular neurons (Figures 3(b)–(d) and
Table 1). Using current injection to evoke action poten-
tials, there was no signiﬁcant diﬀerence in either the
threshold for action potential generation (articular:
464.40 99.87pA, n¼ 16 and cutaneous: 453.50
80.86 pA, n¼ 20, Figure 3(f)) or the AHP (articular:
15.44 2.37ms, n¼ 16 and cutaneous: 18.88 1.97ms,
n¼ 20, Figure 3(g)), but the HPD of articular neuron
action potentials was signiﬁcantly shorter than that of
cutaneous neurons (articular: 3.58 0.28ms, n¼ 16 and
cutaneous: 5.34 0.52ms, n¼ 20, p< 0.01, Figure 3(h)).
All of the neurons recorded from had an inﬂection, or
hump, on the falling phase (Figure 3(e)), which indicates
that they were all putative nociceptors.32
pH sensitivity of articular and cutaneous afferents
To determine the nature of acid-gated currents and puta-
tive diﬀerences between articular and cutaneous aﬀerent
neurons, neurons were exposed to a 5-s pulse of a pH 5.0
solution. If a transient current was recorded, the ASIC
antagonist benzamil (250mM) was applied for 60 s before
reapplying a pH 5.0 solution. In both articular and
cutaneous neurons, the majority of acid-gated currents
were rapidly inactivating transient currents, where inacti-
vation to baseline never fully occurred leaving a small
sustained current recorded throughout the period stimu-
lation (articular: 10/16 neurons and cutaneous: 15/20
neurons, Figure 4(a)). Moreover, the peak transient
phase (T) of these rapidly inactivating currents was sen-
sitive to benzamil inhibition, but the smaller sustained
phase (Ts) was not (articular: T control 15.72 3.68 pA/
pF, T benzamil 2.70 0.92 pA/pF, n¼ 10, p< 0.01,
Figure 4(b); cutaneous: T control 34.05 6.44 pA/pF,
T benzamil 6.29 1.51 pA/pF, n¼ 15, p< 0.001,
Figure 4(c)), thus indicating that the peak transient
acid-gated currents were mediated by ASICs, whereas
the sustained acid-gated current may involve non-ASIC
conductances, although the inability of benzamil and its
derivatives to fully inhibit the sustained phase of ASIC-
mediated currents has been previously documented.36,37
Comparing the magnitude of the ASIC-like currents
between articular and cutaneous neurons, cutaneous
neuron currents were signiﬁcantly larger (34.05 6.44pA/
pF, n¼ 15 vs. 15.72 3.68pA/pF, n¼ 10, p< 0.05,
Figure 4(b) and (c)). However, no signiﬁcant diﬀerence
was observed in the inactivation time constant of these tran-
sient currents (articular: 144.0 15.58ms, n¼ 9 and cuta-
neous: 151.1 15.49ms, n¼ 13), suggesting that the nature
of ASIC subunits responsible for the transient currents
observed is similar between articular and cutaneous neu-
rons. Of the sustained currents recorded, sensitivity to cap-
saicin was demonstrated in approximately half the cases
(articular: 3/6 neurons and cutaneous: 2/5 neurons,
Figure 4(d) and (e).
Chemosensitivity of articular and cutaneous afferents
To investigate the chemosensitivity of articular and cuta-
neous aﬀerent neurons, neurons were exposed to 5-s
pulses of capsaicin (1 mM, TRPV1 agonist), cinnamalde-
hyde (100 mM, transient receptor potential ankyrin 1
[TRPA1] agonist), menthol (100mM, transient receptor
potential melastatin 8 [TRPM8] agonist), and ATP
(50 mM, P2X/P2Y agonist). The percentage of articular
and cutaneous neurons responding to the transient
receptor potential (TRP) channel agonists was highly
similar (Figure 5(a)–(c)), but a signiﬁcantly smaller
proportion of cutaneous neurons displayed a response
to ATP (Figure 5(d), articular: 87.5% responders and
cutaneous: 50.0% responders, p< 0.05). Of the articu-
lar/cutaneous neurons that responded to ATP, currents
were either transient P2X-like responses or sustained
P2Y-like responses (Figure 5(e)) and similar proportions
of responses to ATP were P2Y-like in both articular and
cutaneous neurons (Figure 5(f)).
By comparing the peak current densities for responses
to capsaicin, cinnamaldehyde, menthol, and ATP, we
observed no signiﬁcant diﬀerences in the amplitude of
responses between articular and cutaneous neurons
(Figure 5(g)). Similarly, comparison of the P2X-like
and P2Y-like currents showed that there was no
Table 1. Properties of articular and cutaneous neurons.
Diameter
(mm)
Resting membrane
potential (mV)
AP threshold
(pA)
AP
HPD (ms) AP AHP (ms) AP amplitude (mV)
Articular (n¼ 16) 25.42 1.34 49.88 1.86 464.40 99.87 3.58 0.28 15.44 2.37 35.26 3.24
Cutaneous (n¼ 20) 25.02 1.08 50.10 1.08 453.50 80.86 5.34 0.52** 18.88 1.97 45.37 2.50*
AP: action potential; HPD: half-peak duration; AHP: afterhyperpolarization duration.
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signiﬁcant diﬀerence between the amplitude of responses
between articular and cutaneous neurons (Figure 5(h)).
Discussion
In this study, we have characterized and compared the
neurochemical and electrophysiological properties of
identiﬁed articular and cutaneous sensory neurons in
the mouse. We ﬁnd that cutaneous injection of retro-
grade tracer labels a higher percentage of lumbar DRG
neurons than articular (ankle and knee) injection and
that in both cases, the majority of neurons are peptider-
gic. Comparing the electrophysiological properties of
articular and cutaneous neurons, we ﬁnd that cutaneous
neuron action potential HPD is longer than in articular
neurons and that ASIC-like currents are of signiﬁcantly
Figure 4. pH sensitivity of articular and cutaneous neurons. (a) Example of a transient current evoked by a 5-s application of a pH 5.0
solution (left panel: T labels the peak transient current and Ts labels the sustained phase) that is inhibited by 60 s of benzamil (250mM)
treatment (middle panel) and recovers following a 60-s wash (right panel). (b and c), benzamil inhibition of the T, but not the Ts, phase of
rapidly inactivating currents in articular (n¼ 10) and cutaneous (n¼ 15) neurons. (d) Example traces of a neuron producing a purely sustained
response to low pH (left panel) that was also sensitive to the TRPV1 agonist capsaicin (right panel). (e) Example traces of a neuron producing a
sustained response to low pH (left panel) that was insensitive to the TRPV1 agonist capsaicin (right panel). In (d) and (e), a wash period of at
least 30 s was present between the two stimuli. Numbers in brackets refer to the number of neurons recorded from. *p< 0.05, **p< 0.01
and ***p< 0.001; yp< 0.05 between articular and cutaneous neurons. TRPV1: transient receptor potential vanilloid 1.
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greater amplitude in cutaneous neurons, whereas articu-
lar neurons respond more frequently to ATP than cuta-
neous neurons.
Neurochemical properties of articular and
cutaneous neurons
Although approximately the same volume of RetroBeads
was injected into ankles/knees (2.5ml/1.5ml) and sub-
cutaneously into the plantar aspect (31 ml) of each
hind limb of mice in the articular and cutaneous groups,
we observed that a signiﬁcantly greater proportion of
lumbar DRG neurons were labeled following cutaneous
injection compared with articular injection (Figure 1).
This ﬁnding is to be expected considering that the
number of neurons innervating cutaneous tissue in mam-
mals is usually much greater than that which innervates
the joints. For example, in the cat, aﬀerent neurons in the
posterior and medial articular nerves innervate the knee
number 662 and 628, respectively,38 whereas aﬀerent
neurons in the sural nerve innervate the lateral portion
of the plantar hind paw, numbers 3596 aﬀerent neu-
rons.39 However, it should be noted that subcutaneous
injection could potentially label neurons innervating
structures such as the periosteum, as well as neurons
innervating the skin. Our ﬁnding that the L3 and L4
DRG contain the majority of labeled neurons following
hind paw retrograde tracer injection replicates what
others have identiﬁed.34 Similarly, others have also
found that the L3 and L4 DRG contain the majority
Figure 5. Chemosensitivity of articular and cutaneous neurons. (a–d) Percentage responders and nonresponders to capsaicin, cinna-
maldehyde, menthol, and ATP; total number of neurons tested, articular n¼ 16, cutaneous n¼ 20. (e) Example of a P2X-like response (left
panel) and a P2Y-like response (right panel) in response to ATP. (f) Percentage of ATP responses that were with P2X- or P2Y-like; total
number of responses, articular n¼ 14, cutaneous n¼ 10. (g) Peak current responses to capsaicin (cap, 1mM, n¼ 7 and 9), cinnamaldehyde
(CA, 100 mM, n¼ 7 and 7), menthol (M, 100mM, n¼ 6 and 8) and ATP (50mM, n¼ 14 and 10). (h) Peak current amplitudes of P2X- (n¼ 7
and 4) and P2Y-like (n¼ 7 and 6) responses to ATP. Resp. and no resp. refer to whether a neuron responded to the stimulus *p< 0.05.
10 Molecular Pain 0(0)
of labeled neurons following retrograde tracer injection
into ankle or knee.24,40
With regard to the neurochemical phenotype of
labeled neurons, both articular and cutaneous neurons
contain a mixed population of myelinated (NF-200 posi-
tive) and unmyelinated neurons (peripherin positive),
and the majority of labeled neurons are peptidergic
(CGRP positive; Figure 2). In our immunohistochemis-
try analysis, we found that although the vast majority of
articular neurons were peptidergic (79.38%), 5% were
IB4-positive (Figure 2(e)) and thus likely nonpeptidergic
ﬁbers; in electrophysiology studies, we also observed a
low proportion of IB4-positive articular neurons, 2/16
(12.5%). Previous studies have found either an absence
of IB4 staining in knee joint aﬀerents23,25 or very low
levels (1.5%) of staining,26 whereas the majority of
ankle aﬀerents are CGRP positive.24 Based upon previ-
ous literature, it is thus likely that the IB4-positive neu-
rons we observed innervate the ankle, rather than the
knee. For cutaneous neurons, we also noted a similar
percentage of IB4-positive neurons using immunohisto-
chemistry (26.01%) and electrophysiology (20%). Others
have identiﬁed that neurons innervating the skin in vari-
ous places of the body are IB4-positive at varying pro-
portions27–29 and indeed one other study that used a
diﬀerent retrograde tracer to that used in our study
found that 19% of labeled plantar surface cutaneous
aﬀerents are IB4-positive.30
The general trend, although not signiﬁcant, for
decreased myelinated (NF-200 positive)/increased
unmyelinated (peripherin positive) labeled neurons fol-
lowing cutaneous injection (Figure 2(e)) compared with
articular injection (Figure 2(f)) may be the result of the
higher ratio of unmyelinated C-ﬁbers to A-ﬁbers in those
nerves innervating the skin41–45 compared to the
joints.38,39 However, it should be noted that recent evi-
dence shows that unmyelinated ﬁbers do sometimes
express NF-200 (20%) and that large myelinated
ﬁbers in some cases express peripherin (15%),35 and,
consequently, conclusions about ﬁber type based purely
upon expression of either NF-200 or peripherin alone
should be treated with caution. It is also possible that
RetroBeads are preferentially endocytosed by unmyeli-
nated neurons, which, as described earlier, are more
prevalent in the skin than the joints. Although we have
no evidence for biased labeling, it has been suggested
that other neuronal tracers, such as wheat germ agglu-
tinin and cholera toxin, are selectively taken up by dif-
ferent neuronal populations.46 A second factor to
consider is that neurons may dichotomize, such that
cell bodies in the DRG project, axons that bifurcate
and innervate multiple targets. For example, it has
been shown that 1.6% of neurons innervating the rat
hip joint also project to skin on the left medial portion
of the knee.47
Electrophysiological properties of articular and
cutaneous neurons
No signiﬁcant diﬀerences were observed with regard to
the macroscopic voltage-gated inward currents recorded
from articular and cutaneous neurons (Figure 3(c)
and (d)). With regard to action potential parameters,
the action potential HPD was signiﬁcantly longer in
cutaneous than articular neurons (Figure 3(h)), a pos-
sible explanation for the longer HPD would be enhanced
expression of the voltage-gated sodium channel 1.8
(NaV1.8) because NaV1.8 is largely responsible for the
inﬂection observed during the repolarization phase of
action potentials.48 We observed no signiﬁcant diﬀerence
in AHP duration between articular and cutaneous
neurons (Figure 3(g)), but with regard to the values
reported, it should be noted that a wide range of
values have been published,49–51 which reﬂects not only
likely species diﬀerences but also the methodology used;
here current injection lasted for 80ms, which may inﬂu-
ence the voltage-gated conductances that contribute to
AHP duration.
During inﬂammation, such as that associated with
rheumatoid arthritis, sensory neurons are exposed to a
variety of stimuli that can both activate and sensitize
them, such as prostaglandins, ATP, neuropeptides, and
protons.52,53 Here, we describe the basal characteristics
of two diﬀerent sensory neuron populations and deter-
mine their sensitivity to a variety of agonists for trans-
duction channels: capsaicin (TRPV1), cinnamaldehyde
(TRPA1), menthol (TRPM8), ATP (P2X/P2Y), and
protons (e.g. ASICs and TRPV1). Tissue acidosis is a
hallmark of inﬂammation and protons can induce
depolarization via activation of ASICs, TRPV1, and cer-
tain G protein coupled receptors, as well as by inhibiting
certain two-pore domain Kþ channels.54 In both articu-
lar and cutaneous neurons, the majority of proton
responses were ASIC-like, as determined by their
inhibition by benzamil (64% and 72%, respectively
Figure 4(a)–(c)). The percentage of transient ASIC-like
currents in cutaneous neurons is slightly higher than
what we have previously reported for a similar popula-
tion of mouse cutaneous neurons36 but is similar to what
others have shown in the rat.17 The amplitude of
ASIC-like currents in cutaneous neurons was signiﬁ-
cantly larger than the amplitude of ASIC-like currents
in articular neurons, which supports our previous obser-
vation, using a diﬀerent retrograde tracer, that ASIC-like
currents are of larger magnitude in cutaneous neurons
compared with nonidentiﬁed neurons.36 Our observation
that all ASIC-like currents in cutaneous neurons were
rapidly inactivating also supports our previous data36
and that of others, which has shown that the rapidly
inactivating ASIC3 subunit is the major contributor to
hind paw skin neuron ASIC currents, with only a very
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small percentage of neurons (4.7%) expressing the
relatively slowly inactivating ASIC1a.17 To our know-
ledge, this is the ﬁrst description of ASIC-like currents
in identiﬁed articular neurons, although immunohisto-
chemistry has shown that ASIC3 is expressed by about
30% of sensory neurons that innervate the knee.55 In
both articular and cutaneous neurons, approximately
half of the sustained responses to protons occurred in
neurons that were also capsaicin sensitive, which indi-
cates that although TRPV1 is responsible for many of
the sustained currents observed that other conductances
are also involved, an observation that others and our-
selves have previously observed in diﬀerent
species.8,10,11,36,56
In both articular and cutaneous neurons, between 40
and 50% of neurons responded to agonists of TRPV1,
TRPA1, and TRPM8 with there being no signiﬁcant
diﬀerence in the magnitude of responses. The reported
sensitivity of DRG neurons to ligands of TRP channels
varies depending upon the type of neurons analyzed and
the culture conditions used. For example, TRPV1 sensi-
tivity is reported from 16.5% in DRG dissociated from
adult mice57 to 83% in DRG dissociated from neonatal
mice and cultured with nerve growth factor;58 based
upon functional analysis, TRPA1 and TRPM8 expres-
sion is reported as being approximately 30% and 20%,
respectively.59–61 Therefore, the sensitivity of both
articular and cutaneous neurons to TRP channel agon-
ists does not appear to be signiﬁcantly enhanced or
depressed compared with the general neuronal popula-
tion as reported by others. The sensitivity of articular
neurons to capsaicin was greater than the expression
level detected by our immunohistochemistry data, i.e.
only 20.83% TRPV1/RetroBead colocalization was
observed using immunohistochemistry (Figure 2(e)),
but electrophysiology found that 43.75% of neurons
responded (Figure 5(a)); a similar, but smaller diﬀerence
was observed for cutaneous neurons. This diﬀerence
likely indicates the increased sensitivity of the electro-
physiology technique, especially considering the small
current amplitudes and indeed a similar disparity
between immunohistochemistry and electrophysiology
determination of TRPV1 expression has been previously
noted.57 Finally, whereas 87.5% of articular neurons
responded to ATP, only 50% of cutaneous neurons
responded, which suggests that articular neurons are
more attuned to extracellular ATP levels. The ﬁnding
that articular neurons are primed to sense ATP may indi-
cate that ﬂuctuation in articular ATP concentration is an
initial step when damage to the joint occurs.
Conclusions
This study is the ﬁrst to combine immunohistochemical
and functional comparative analysis of identiﬁed
articular and cutaneous neurons. Our ﬁndings demon-
strate that cutaneous neurons have larger ASIC-like
responses than articular neurons and that articular neu-
rons respond more frequently to ATP.
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